Variant report
Variant | rs16938608 |
---|---|
Chromosome Location | chr8:49621293-49621294 |
allele | A/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:49605600-49621800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr8:49612800-49626400 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr8:49616200-49622400 | Enhancers | Esophagus | oesophagus |
4 | chr8:49617200-49622400 | Enhancers | Fetal Heart | heart |
5 | chr8:49617600-49621800 | Enhancers | Right Ventricle | heart |
6 | chr8:49617800-49621600 | Enhancers | Left Ventricle | heart |
7 | chr8:49618000-49626000 | Weak transcription | Fetal Kidney | kidney |
8 | chr8:49618200-49621800 | Enhancers | Right Atrium | heart |
9 | chr8:49618200-49628000 | Weak transcription | Fetal Lung | lung |
10 | chr8:49619000-49626200 | Weak transcription | Spleen | Spleen |
11 | chr8:49621000-49621400 | Flanking Active TSS | Breast Myoepithelial Primary Cells | Breast |
12 | chr8:49621000-49621600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr8:49621000-49621600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
14 | chr8:49621000-49621600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
15 | chr8:49621000-49621800 | Flanking Active TSS | NHEK | skin |
16 | chr8:49621200-49621400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr8:49621200-49621400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr8:49621200-49621400 | Enhancers | Brain Germinal Matrix | brain |
19 | chr8:49621200-49621600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr8:49621200-49621600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr8:49621200-49621600 | Flanking Active TSS | HMEC | breast |
22 | chr8:49621200-49621800 | Enhancers | Ovary | ovary |
23 | chr8:49621200-49622400 | Enhancers | Placenta | Placenta |